H.R.6576 - Drug-Price Transparency in Communications Act115th Congress (2017-2018)
|Sponsor:||Rep. Schakowsky, Janice D. [D-IL-9] (Introduced 07/26/2018)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 07/27/2018 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Related Bills: H.R.6576 — 115th Congress (2017-2018)All Information (Except Text)
A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.